Kala - KALA

La vendita allo scoperto per Kala Bio dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Kala Bio. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Kala Bio (NASDAQ:KALA) Azioni, Report sulle vendite allo scoperto

KALA BIO INC

Kala Bio

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Citigroup analyst Ronald Josey maintains Fiverr Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FVRR#NYSE">FVRR</a>) with a Buy and lowers the price target from $40 to $33.

News

Price Target

Analyst Ratings

FVRR

Citigroup Maintains Buy on Fiverr Intl, Lowers Price Target to $33

Citigroup analyst Christopher Allen maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Neutral and raises the price target from $100 to $120.

HOOD

Citigroup Maintains Neutral on Robinhood Markets, Raises Price Target to $120

Citigroup analyst Steven Zaccone maintains Lowe's Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) with a Neutral and lowers the price target from $253 to $242.

Citigroup Maintains Neutral on Lowe's Companies, Lowers Price Target to $242

Many shoppers think of returns as a no harm, no foul transaction. If they deem a purchase unnecessary, and the product is unused and easy to resell, they're largely right.&nbsp;
However, retailers are now telling <a href="https://www.businessinsider.com/return-fraud-amazon-shipping-retail-theft-wardrobing-online-shopping-2025-7">Business Insider</a> that the returns are becoming a major issue. Especially as outright return fraud — in the form of empty packages, swapped out items, claiming failed deliveries, or abusing generous return polices — is ramping up.
&#8220;Consumers who would never go into a physical store and take an item off without paying and stealing are actually being trained socially that it&#8217;s actually acceptable to take advantage of retailers in these small ways,&#8221; Narvar Vice President of Consumer Strategy David Morin said. &#8220;They think it&#8217;s OK, right? Stick it to the man.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can <a href="https://www.benzinga.com/money/mode-mobile-2">invest today for just $0.30/share.</a></li>
<li>Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora &amp; MGM—<a href="https://www.benzinga.com/money/rad-intel">Just $0.63 Before NASDAQ Launch</a></li>
</ul>
A 2024 <a href="https://www.businesswire.com/news/home/20241230601195/en/Appriss-Retail-Annual-Research-Fraudulent-Returns-and-Claims-Cost-Retailers-%24103B-in-2024">report</a> by Appriss Retail and Deloitte found that last year the total value of returned merchandise in the U.S. reached $685 billion, or 13.21% of total retail sales. Of those returns, 15.14% were fraudulent, resulting in a $103 billion loss for retailers.&nbsp;
Morin told Business Insider that it's hard to determine exactly who is behind all of these fraudulent returns, but that it's clear a pretty expansive group of people made up of both ordinary consumers and organized criminals is involved.
Last summer, Narvar's 8th Annual State of Returns <a href="https://www.prnewswire.com/news-releases/narvar-state-of-returns-2024-report-highlights-growing-impact-of-returns-on-retail-margins-and-customer-loyalty-302227590.html">report</a> found that 57% of shoppers said they had participated in return fraud at least once. Return fraud incidents, the report said, were up by 16 percentage points year-over-year.
&#8220;There seems to be this mentality that consumers feel entitled to do it,&#8221; Loop Senior Vice President of Marketing Jessica Meher told Business Insider.
Trending: $100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.
E-commerce has made return fraud easier to participate in, the outlet says, because overwhelmed warehouse employees who are receiving these packages are less likely to examine their contents closely. Meanwhile, employees at brick and mortar stores have the bandwidth to ensure the products are unused and match the original purchase.
Social media is also adding to the problem, as people take to platforms like TikTok and Reddit to post their best tips for getting free refunds.
"It&#8217;s almost like coupon sites where consumers have been trained to look for coupons and discounts,&#8221; Meher said. &#8220;That&#8217;s starting to happen with what companies offer loose return policies.&#8221;
For many people, this sort of low-level fraud feels like a victimless crime that only affects soulless corporations, Business Insider says. People assume that because these companies have extended such generous return policies, they really don't care all that much.
See Also: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
It turns out, that's not the case. Many retailers, both large and small, have started changing their return policies in hopes of slowing their losses. Tightening return windows, implementing stricter policies, and even tailoring those policies for individual customers are among the most popular reactions to return fraud, the outlet found.
Progress is slow, though, because many companies are worried about alienating their most loyal customer base. "How do I make sure that I don&#8217;t piss off my good customers?," is one of the most pressing questions retailers are considering when reassessing their return policies, Meher said.
Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
Image: Shutterstock

Personal Finance

The Return Fraud Epidemic: How $103 Billion In Returns Are Costing Shopping And Sellers Big

US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) has outperformed the market over the past 5 years by 17.03% on an annualized basis producing an average annual return of 30.9%. Currently, US Foods Hldg has a market capitalization of $19.28 billion. 
Buying $1000 In USFD: If an investor had bought $1000 of USFD stock 5 years ago, it would be worth $4,141.65 today based on a price of $83.33 for USFD at the time of writing.
<h3>US Foods Hldg's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1754002820_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

USFD

Here's How Much You Would Have Made Owning US Foods Hldg Stock In The Last 5 Years

Maxim Group analyst Matthew Galinko initiates coverage on Galaxy Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXY#NASDAQ">GLXY</a>) with a Buy rating and announces Price Target of $40.

Initiation

GLXY

Maxim Group Initiates Coverage On Galaxy Digital with Buy Rating, Announces Price Target of $40

Ladenburg Thalmann analyst Christopher Nolan upgrades Medallion Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFIN#NASDAQ">MFIN</a>) from Neutral to Buy and announces $12 price target.

Upgrades

MFIN

Ladenburg Thalmann Upgrades Medallion Financial to Buy, Announces $12 Price Target

Editor&#8217;s Note: The story has been updated with statement from Cognizant
Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) has accused IT services provider Cognizant Technology Solutions Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>) of gross negligence and breach of trust after a cyberattack caused widespread disruption and nearly <a target="_blank" href="https://www.benzinga.com/news/23/09/34689201/why-clorox-stock-is-sliding-monday" rel="noreferrer noopener">$380 million in damages</a>.
According to Clorox, the root cause of the attack was Cognizant's failure to follow basic cybersecurity protocols it had agreed to uphold under a <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">long-standing partnership</a>.
For more than a decade, Clorox relied on Cognizant to operate its employee service desk, including tasks such as password recovery and credential resets.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/05/45209366/clorox-stock-drops-after-worse-than-expected-q3-results-heightened-macroeconomic-uncertainties-lowered-sales-ceo-says" target="_blank" rel="noreferrer noopener">Clorox Stock Drops After Worse-Than-Expected Q3 Results: &#8216;Heightened Macroeconomic Uncertainties&#8217; Lowered Sales, CEO says</a>
The responsibility came with a clear requirement: no credentials would be reset without properly authenticating the requester. Despite repeated assurances, Cognizant allegedly failed to follow these procedures.
In an emailed statement to Benzinga, Cognizant spokesperson said, &#8220;It is shocking that a corporation the size of Clorox had such an inept internal cybersecurity system to mitigate this attack. Clorox has tried to blame us for these failures, but the reality is that Clorox hired Cognizant for a narrow scope of help desk services which Cognizant reasonably performed.  Cognizant did not manage cybersecurity for Clorox.&#8220;
On Aug. 11, 2023, a cybercriminal contacted the Cognizant-run service desk and was given direct access to Clorox's network credentials without facing any authentication checks.
This lapse happened multiple times that day, giving the attacker unfettered access to the company's systems. Clorox says audio recordings show Cognizant handing over credentials with no verification.
<ul class="wp-block-list">
<li>Cybercriminal: I don't have a password, so I can't connect.</li>
<li>Cognizant Agent: Oh, ok. Ok. So let me provide the password to you ok?</li>
<li>Cybercriminal: Alright. Yep. Yeah, what's the password?</li>
<li>Cognizant Agent: Just a minute. So it starts with the word "Welcome…</li>
</ul>
The cyberattack that followed crippled Clorox's corporate network, disrupted its supply chain, and significantly impaired its ability to fulfill orders.
According to the lawsuit <a target="_blank" href="https://www.documentcloud.org/documents/26025404-clorox-versus-cognizant-complaint/" rel="noreferrer noopener">filed</a> by Clorox, Cognizant's mishandling of the initial credential requests was compounded by a botched incident response and disaster recovery effort, further worsening the damage.
Clorox maintains that Cognizant ignored the company's clearly outlined security procedures, which were designed to prevent exactly such an attack.
Despite touting its cybersecurity expertise and claiming to have trained its service desk staff in these protocols, Cognizant's actions—or inactions—revealed what Clorox called a "devastating lie."
The company says the breach could have been entirely avoided with proper training and adherence to security protocols.
Instead, Clorox was left dealing with over $49 million in direct recovery costs and hundreds of millions more in business interruption losses.
Meanwhile, Cognizant reported $20 billion in revenue in 2024, with no apparent hit to its brand or bottom line.
CTSH Price Action:&nbsp;Cognizant Tech Solns shares were up 0.72% at $77.34 on Wednesday,&nbsp;<a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">according to Benzinga Pro.</a> The stock is trading within its 52-week range of $65.52 to $90.82.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46565953/lockheed-martin-confirms-talks-with-us-over-trumps-175-billion-golden-dome-missile-shield-ceo-james-taiclet-says-no-contracts-yet-lmt-is-all-in" target="_blank" rel="noreferrer noopener">Lockheed Martin Confirms Talks With US Over Trump&#8217;s $175 Billion &#8216;Golden Dome&#8217; Missile Shield — CEO James Taiclet Says No Contracts Yet, LMT Is &#8216;All In&#8217;</a></li>
</ul>
Image via Mdisk/Shutterstock

Legal

Movers

General

CTSH

Clorox Claims Cognizant Handed Credentials To Hacker, Ignored Security Protocols (UPDATED)

WIIM

COHU

COHU stock has given up its prior gain. Cohu shares were trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.

Lake Street analyst Frank Takkinen maintains Pulmonx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) with a Buy and lowers the price target from $12 to $8.

LUNG

Lake Street Maintains Buy on Pulmonx, Lowers Price Target to $8

Lake Street analyst Rob Brown maintains Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Buy and raises the price target from $14 to $18.

APLD

Lake Street Maintains Buy on Applied Digital, Raises Price Target to $18

Editor&#8217;s Note: The story has been updated with statement from Roblox
Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) shares are falling after news broke of a new lawsuit seeking to hold the gaming platform and Discord accountable for allegedly enabling the sexual exploitation of a minor. 
The suit, underscoring claims of systemic failures in child safety protections, accuses both companies of creating platforms that allowed a predator to target and abuse the plaintiff, who was a minor at the time and is now just entering adulthood.
According to the complaint, the predator was able to easily identify, groom, and exploit the plaintiff due to design flaws and a lack of safety measures within the apps. 
In an emailed statement to Benzinga, Roblox spokesperson said, &#8220;As a policy we cannot comment on pending litigation, but Roblox is deeply committed to the safety and well-being of our community, with tens of millions having positive experiences every day. Protecting children is a top priority, and we invest significant resources in advanced safety technology, including a combination of machine learning and human moderation teams working 24/7 to detect and address inappropriate content and behavior. This includes attempts to share personal information or direct users off platform, where safety standards and moderation may be less stringent than ours. We also provide significant resources for parents and do not allow any user-to-user image sharing or sexual conversation on our platform. We partner with law enforcement and other organizations that combat the sexual exploitation of children around the world. We are always evolving our safety practices to promote a secure and positive experience for everyone."
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/07/46538469/roblox-expands-into-edtech-with-google-bbc-games" rel="noreferrer noopener">Roblox Expands Into EdTech With Google, BBC Games</a>
<h2 class="wp-block-heading">The Digital Predator&#8217;s Playbook: From Roblox to Discord</h2>
The predator first contacted the child through Roblox, then directed communication to Discord, where voice, video, and text messaging were used to coerce the victim into sharing explicit content and potentially meeting in person.
The complaint asserts that both companies failed to invest in basic safeguards despite knowing the risks their platforms posed to minors.
The <a target="_blank" href="https://www.anapolweiss.com/roblox-and-discord-complaint-florida-minor.pdf" rel="noreferrer noopener">lawsuit</a> highlights how Roblox and Discord misrepresented the safety of their platforms, misleading parents into believing they were appropriate for children.
Plaintiff&#8217;s father allowed usage of these apps based on these assurances, only to later discover the devastating consequences. The plaintiff&#8217;s family learned the truth only after the exploitation had occurred. The harm suffered, according to the complaint, is severe and lasting.
The suit emphasizes that the plaintiff&#8217;s case is not an isolated incident but one among many. It frames the litigation as a broader challenge against tech platforms that prioritize profits over child safety, accusing them of knowingly enabling exploitation.
<h2 class="wp-block-heading">Roblox: A &#8220;Metaverse&#8221; Without Mature Safeguards?</h2>
Roblox, launched in 2006, is a free online gaming platform with over 40 million user-generated &#8220;experiences.&#8221; It is accessible across various devices, including phones, tablets, and gaming consoles.
While Roblox claims to require parental permission for underage users, the platform does not verify age or confirm parental approval, allowing children of any age to sign up and interact with adult users.
Although Roblox recently limited direct messaging for users under 13, it still relies on self-reported birthdates, allowing children to bypass restrictions. Conversely, adults can enter fake birthdates to pose as minors and continue targeting children.
Leaked documents show Roblox&#8217;s internal discussions about avatar nudity and sexualized content, suggesting a level of awareness and control over what is allowed. Despite this, the platform continues to host exploitative content, including &#8220;condo games&#8221; and virtual strip clubs.
<h2 class="wp-block-heading">The Broader Implications: A Call for Accountability and Regulatory Scrutiny</h2>
This lawsuit against Roblox and Discord is emblematic of a growing societal reckoning with the responsibilities of social media and gaming platforms. As these digital spaces become increasingly integrated into the lives of children and teenagers, the pressure mounts on tech companies to move beyond self-regulation and implement robust, verifiable safety measures.
As the legal proceedings unfold, the outcome of this case could set a significant precedent, potentially forcing a paradigm shift in how major tech platforms approach child safety and compelling them to invest substantially more in protecting their youngest and most vulnerable users.
Price Action: RBLX stock is trading lower by 3.10% to $116.47 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46568764/obama-slams-trumps-coup-allegations-over-2016-election-as-outrageous-and-ridiculous-in-rare-public-rebuke" target="_blank" rel="noreferrer noopener">Obama Slams Trump&#8217;s &#8216;Coup&#8217; Allegations Over 2016 Election As &#8216;Outrageous&#8217; And &#8216;Ridiculous&#8217; In Rare Public Rebuke</a></li>
</ul>
Image via Shutterstock

Large Cap

Tech

RBLX

Lawsuit Highlights Secret Dangers Lurking Behind Roblox Avatars And Discord Chats - What Parents Need to Know (UPDATED)

Loop Capital analyst Garik Shmois downgrades Carlisle Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>) from Buy to Hold and lowers the price target from $430 to $395.

Downgrades

Loop Capital Downgrades Carlisle Companies to Hold, Lowers Price Target to $395

Loop Capital analyst Mark Schappel downgrades SPS Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPSC#NASDAQ">SPSC</a>) from Buy to Hold and lowers the price target from $175 to $120.

SPSC

Loop Capital Downgrades SPS Commerce to Hold, Lowers Price Target to $120

Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) has outperformed the market over the past 15 years by 1.69% on an annualized basis producing an average annual return of 13.89%. Currently, Starbucks has a market capitalization of $101.62 billion. 
Buying $1000 In SBUX: If an investor had bought $1000 of SBUX stock 15 years ago, it would be worth $7,081.81 today based on a price of $89.40 for SBUX at the time of writing.
<h3>Starbucks's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1754001915_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SBUX

Here's How Much $1000 Invested In Starbucks 15 Years Ago Would Be Worth Today

Barclays analyst Manav Patnaik maintains S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) with a Overweight and raises the price target from $610 to $620.

SPGI

Barclays Maintains Overweight on S&P Global, Raises Price Target to $620

Barclays analyst Saket Kalia maintains Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) with a Overweight and raises the price target from $695 to $715.

Barclays Maintains Overweight on Tyler Technologies, Raises Price Target to $715

Barclays analyst Andrew Mok upgrades Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) from Underweight to Equal-Weight and raises the price target from $9 to $13.

ALHC

Barclays Upgrades Alignment Healthcare to Equal-Weight, Raises Price Target to $13

Barclays analyst Seth Sigman upgrades Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) from Equal-Weight to Overweight and raises the price target from $173 to $185.

Barclays Upgrades Sprouts Farmers Market to Overweight, Raises Price Target to $185

Barclays analyst Jeffrey Bernstein maintains Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Overweight and raises the price target from $410 to $440.

WING

Barclays Maintains Overweight on Wingstop, Raises Price Target to $440

Earnings

Press Releases

KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

Financing

KALA BIO Announces $10,750,000 Private Placement

Management

KALA BIO Announces Chief Executive Officer Transition

Health Care

KALA BIO to Present at TD Cowen 45th Annual Health Care Conference

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update

KALA BIO to Present at Jefferies Global Healthcare Conference

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

KALA

ABVC BioPharma

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Aligos Therapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Gain Therapeutics

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Lantern Pharma

MAIA Biotechnology

Mural Oncology

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

PepGen

Pluri

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

RenovoRx

Senti Biosciences

Shattuck Labs

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

Exicure

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

Comments

Kala Bio

Vendite allo scoperto

Kala Bio (NASDAQ:KALA) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO